Prognostic factors and treatment impact on overall survival in patients with renal neuroendocrine tumour.

ABSTRACT:

Background

Renal neuroendocrine neoplasms (R-NEN) are exceptionally rare tumours characterized by high mortality rates.

Objective

The objective of this study is to analyse prognostic factors and treatment impact on overall survival in patients with R-NEN.

Design setting and participants

We identified all patients with R-NEN in the National Cancer Database (NCDB) from 2004 to 2019 and identified prognostic factors for improved survival.

Results and limitations

Of 542 R-NEN cases, 166 (31%) were neuroendocrine tumour grade 1 (NET-G1), 14 (3%) were neuroendocrine tumour grade 2 (NET-G2), 169 (31%) were neuroendocrine carcinoma (NEC-NOS), 18 (3%) were large cell neuroendocrine carcinoma (LC-NEC) and 175 (32%) were small cell neuroendocrine carcinoma (SC-NEC). Media

SUBMITTER: Omidele OO 

PROVIDER: S-EPMC11168774 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature